Aperivue RADS

Lung Cancer Screening CT Report Generator

Structured reporting with Lung-RADS v2022 · Multi-nodule · S modifier · PACS-ready output

Pre-assessment

Select if the study is incomplete (Cat 0) or if there are no nodules / only benign findings (Cat 1). Otherwise, leave as "None" to proceed to nodule assessment.

Nodule Assessment

Nodules

Nodule Type
Scan Context

Is this nodule seen on a baseline scan, a new finding, stable, or growing?

S Modifier — Additional Suspicious Features

Select any additional features that warrant upgrading to a category with the S modifier or 4X.

Select nodule type to begin.

Auto-generated from findings

LOW-DOSE CHEST CT — LUNG CANCER SCREENING

COMPARISON: None available.

FINDINGS:

Pulmonary Nodules:
1. Nodule 1 (Not specified):
   baseline scan.

Mediastinum:
No significant mediastinal or hilar lymphadenopathy.

IMPRESSION:
No significant findings. Continue annual screening with LDCT.

Lung-RADS v2022 — assessment categories

Malignancy likelihood and management by ACR Lung-RADS v2022 category. Management strings mirror this calculator's output.

CategoryMalignancy likelihoodTypical management
Lung-RADS 0n/a (incomplete)Additional imaging or comparison needed (prior CT for comparison or complete lung imaging).
Lung-RADS 1<1%Continue annual screening with LDCT (LDCT in 12 months).
Lung-RADS 2<1%Continue annual screening with LDCT (LDCT in 12 months).
Lung-RADS 31–2%LDCT in 6 months.
Lung-RADS 4A5–15%LDCT in 3 months; PET/CT may be used.
Lung-RADS 4B>15%Tissue sampling, PET/CT, or both; management as clinically indicated.
Lung-RADS 4X>15%Tissue sampling and/or PET/CT, with additional workup as indicated.

Key decision rules (v2022)

  • Nodule type (solid, part-solid, or ground-glass [GGN]) is the first branch point; for part-solid nodules the solid-component size, not the total size, drives the category.
  • Solid nodules: <6 mm is category 1, 6 to <8 mm is category 3, 8 to <15 mm is category 4A, and ≥15 mm is category 4B (baseline or new).
  • Part-solid nodules: a solid component <4 mm scores category 2–3, 4 to <6 mm scores category 4A, and ≥6 mm scores category 4B (baseline or new).
  • Ground-glass nodules: <30 mm is category 2 at baseline (or 3 if new); ≥30 mm is category 3.
  • New vs stable vs growing changes the threshold: a stable nodule ≥12 months is downgraded toward category 2, while a growing nodule is upgraded (e.g. a solid nodule growing to ≥8 mm becomes category 4B).
  • The S modifier flags a clinically significant or potentially significant non-Lung-RADS finding (e.g. spiculation, lymphadenopathy, direct invasion, pleural effusion); when any suspicious feature is present the assessment is escalated to category 4X.
  • Category 0 is assigned when prior CT is unavailable for comparison or the lungs are not fully imaged; category 1 also covers a completely calcified nodule or a fat-density (hamartoma) nodule.

Disclaimer: This tool is for educational and research purposes only. It is not a medical device and has not been cleared or approved by the FDA, KFDA/MFDS, or any regulatory authority. It is not intended for clinical diagnosis or treatment decisions. It does not replace professional medical judgment. Always correlate with clinical findings and institutional protocols.

Reference:ACR Lung-RADS v2022 — American College of Radiology. Lung CT Screening Reporting & Data System (Lung-RADS).